These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3192225)

  • 21. Principles for the safety evaluation of cosmetic powders.
    Steiling W; Almeida JF; Assaf Vandecasteele H; Gilpin S; Kawamoto T; O'Keeffe L; Pappa G; Rettinger K; Rothe H; Bowden AM
    Toxicol Lett; 2018 Nov; 297():8-18. PubMed ID: 30125618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cosmetic products : Safety aspects].
    Platzek T; Krätke R; Schulz C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):610-4. PubMed ID: 20464352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assessment of the sensitizing potency of cosmetic ingredients and commodities. How will the ingredients of cosmetics and commodities be tested in Europe today and tomorrow?].
    Peiser M; Platzek T; Luch A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):373-9. PubMed ID: 22373851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cosmetovigilance in India: Need of the day.
    Sarma P; Kumar H; Medhi B
    Indian J Pharmacol; 2017; 49(5):341-343. PubMed ID: 29515273
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety assessment of cosmetic ingredients present in technical information files of finished products.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():94-114. PubMed ID: 18806455
    [No Abstract]   [Full Text] [Related]  

  • 26. REACH: impact on the US cosmetics industry?
    Pouillot A; Polla B; Polla A
    J Cosmet Dermatol; 2009 Mar; 8(1):3-7. PubMed ID: 19250158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Esthetics, cosmetics and ophthalmology].
    Kassir M; Tham-Kassir H
    J Fr Ophtalmol; 2001 May; 24(5):537-45. PubMed ID: 11397994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
    McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modernizing regulation of cosmetic products: Reintroduction of the Personal Care Products Safety Act.
    Nguyen HP; Bergfeld WF; Forman HP; Belsito DV; Bolognia JL
    J Am Acad Dermatol; 2018 Aug; 79(2):403-405. PubMed ID: 29625132
    [No Abstract]   [Full Text] [Related]  

  • 30. Patch testing with patients' own cosmetics and toiletries--results of the IVDK*, 1998-2002.
    Uter W; Balzer C; Geier J; Frosch PJ; Schnuch A
    Contact Dermatitis; 2005 Oct; 53(4):226-33. PubMed ID: 16191021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety data requirements for the purposes of the Cosmetics Directive.
    Manou I; Eskes C; de Silva O; Renner G; Zuang V
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():21-6. PubMed ID: 16194138
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety Assessment of Alkyl Esters as Used in Cosmetics.
    Fiume MM; Heldreth BA; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2015 Sep; 34(2 Suppl):5S-69S. PubMed ID: 26362120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vigilance in industry: cosmetics and household cleaning products. Balance sheet of case report from 2005 to 2007.
    Kornfeld-Lecanu S; Zajaczkowski F; Dubourg S; Martin L; Lefort S; Siest S
    Clin Exp Dermatol; 2010 Dec; 35(8):874-80. PubMed ID: 20718782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American beauty: an analytical view of the past and current effectiveness of cosmetic safety regulations and future direction.
    Termini RB; Tressler L
    Food Drug Law J; 2008; 63(1):257-74. PubMed ID: 18561461
    [No Abstract]   [Full Text] [Related]  

  • 35. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
    Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
    Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The European regulation for cosmetics : Legislative aspect from the German point of view].
    Butschke A; Dross A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):606-9. PubMed ID: 20458455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consumer groups challenge safety of cosmetics.
    Epstein HA
    Skinmed; 2010; 8(6):352-3. PubMed ID: 21413653
    [No Abstract]   [Full Text] [Related]  

  • 38. California enacts Safe Cosmetics Act.
    Washam C
    Environ Health Perspect; 2006 Jul; 114(7):A402. PubMed ID: 16835040
    [No Abstract]   [Full Text] [Related]  

  • 39. Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products.
    Kwa M; Welty LJ; Xu S
    JAMA Intern Med; 2017 Aug; 177(8):1202-1204. PubMed ID: 28654953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cosmetovigilance: definition, regulation and use "in practice".
    Vigan M; Castelain F
    Eur J Dermatol; 2014; 24(6):643-9. PubMed ID: 25672787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.